311 related articles for article (PubMed ID: 21947829)
21. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
Veerman AJ; Kamps WA; van den Berg H; van den Berg E; Bökkerink JP; Bruin MC; van den Heuvel-Eibrink MM; Korbijn CM; Korthof ET; van der Pal K; Stijnen T; van Weel Sipman MH; van Weerden JF; van Wering ER; van der Does-van den Berg A;
Lancet Oncol; 2009 Oct; 10(10):957-66. PubMed ID: 19747876
[TBL] [Abstract][Full Text] [Related]
22. Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL).
Kotecha RS; Powers N; Lee SJ; Murray KJ; Carter T; Cole C
Pediatr Blood Cancer; 2010 Jul; 54(7):934-40. PubMed ID: 20127847
[TBL] [Abstract][Full Text] [Related]
23. Osteonecrosis in children treated for acute lymphoblastic leukemia: a magnetic resonance imaging study after treatment.
Ojala AE; Lanning FP; Pääkkö E; Lanning BM
Med Pediatr Oncol; 1997 Oct; 29(4):260-5. PubMed ID: 9251731
[TBL] [Abstract][Full Text] [Related]
24. Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database.
Högler W; Wehl G; van Staa T; Meister B; Klein-Franke A; Kropshofer G
Pediatr Blood Cancer; 2007 Jan; 48(1):21-7. PubMed ID: 16317756
[TBL] [Abstract][Full Text] [Related]
25. Antileukemic Efficacy of Continuous vs Discontinuous Dexamethasone in Murine Models of Acute Lymphoblastic Leukemia.
Ramsey LB; Janke LJ; Payton MA; Cai X; Paugh SW; Karol SE; Kamdem Kamdem L; Cheng C; Williams RT; Jeha S; Pui CH; Evans WE; Relling MV
PLoS One; 2015; 10(8):e0135134. PubMed ID: 26252865
[TBL] [Abstract][Full Text] [Related]
26. Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
Toksvang LN; Andrés-Jensen L; Rank CU; Niinimäki R; Nersting J; Nielsen SN; Mogensen SS; Harila-Saari A; Abrahamsson J; Joelsson J; Overgaard UM; Quist-Paulsen P; Griškevičius L; Jónsson ÓG; Vaitkevičienė G; Frandsen TL; Toft N; Grell K; Schmiegelow K
Cancer Chemother Pharmacol; 2021 Nov; 88(5):911-917. PubMed ID: 34145469
[TBL] [Abstract][Full Text] [Related]
27. Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Toft N; Birgens H; Abrahamsson J; Griškevičius L; Hallböök H; Heyman M; Klausen TW; Jónsson ÓG; Palk K; Pruunsild K; Quist-Paulsen P; Vaitkeviciene G; Vettenranta K; Asberg A; Helt LR; Frandsen T; Schmiegelow K
Eur J Haematol; 2016 Feb; 96(2):160-9. PubMed ID: 25867866
[TBL] [Abstract][Full Text] [Related]
28. [Development of aseptic osteonecrosis during the treatment of acute lymphoblastic leukemia: review of the literature and author's own data].
Baranova OIu; Shirin AD; Falaleeva NA; Osmanov DSh
Ter Arkh; 2011; 83(7):26-32. PubMed ID: 21894748
[TBL] [Abstract][Full Text] [Related]
29. Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol.
te Winkel ML; Pieters R; Hop WC; Roos JC; Bökkerink JP; Leeuw JA; Bruin MC; Kollen WJ; Veerman AJ; de Groot-Kruseman HA; van der Sluis IM; van den Heuvel-Eibrink MM
Bone; 2014 Feb; 59():223-8. PubMed ID: 24287213
[TBL] [Abstract][Full Text] [Related]
30. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
31. Avascular necrosis of the right elbow occuring while on UKALL 2003 protocol.
Francis S; Johnson K; Darbyshire P
Eur J Haematol; 2008 Aug; 81(2):164. PubMed ID: 18363872
[No Abstract] [Full Text] [Related]
32. [Whole-body MR imaging in children with suspected osteonecrosis after intensive chemotherapy: preliminary results].
Beer M; Stenzel M; Girschick H; Schlegel PG; Darge K
Rofo; 2008 Mar; 180(3):238-45. PubMed ID: 18278731
[TBL] [Abstract][Full Text] [Related]
33. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95.
Bürger B; Beier R; Zimmermann M; Beck JD; Reiter A; Schrappe M
Pediatr Blood Cancer; 2005 Mar; 44(3):220-5. PubMed ID: 15514916
[TBL] [Abstract][Full Text] [Related]
34. Osteonecrosis in children treated for lymphoma or solid tumors.
Niinimäki RA; Harila-Saari AH; Jartti AE; Seuri RM; Riikonen PV; Pääkkö EL; Möttönen MI; Lanning M
J Pediatr Hematol Oncol; 2008 Nov; 30(11):798-802. PubMed ID: 18989155
[TBL] [Abstract][Full Text] [Related]
35. Bone pain at leukemia diagnosis and other risk factors for symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
Barzilai-Birenboim S; Yacobovich J; Zalcberg Y; Arad-Cohen N; Avrahami G; Gilad G; Litichever N; Izraeli S; Elitzur S
Pediatr Blood Cancer; 2021 Aug; 68(8):e29033. PubMed ID: 33788395
[TBL] [Abstract][Full Text] [Related]
36. Osteonecrosis of the Shoulders in Pediatric Patients Treated for Leukemia or Lymphoma: Single-Institutional Experience.
Kaste SC; DeFeo BM; Neel MD; Weiss KS; Fernandez-Pineda I; Ness KK
J Pediatr Orthop; 2019 Feb; 39(2):104-110. PubMed ID: 28452860
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow changes on MRI in children with acute lymphoblastic leukaemia 5 years after treatment.
Ojala AE; Pääkkö E; Lanning FP; Harila-Saari AH; Lanning BM
Clin Radiol; 1998 Feb; 53(2):131-6. PubMed ID: 9502090
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure? -- BME/AON and hyperbaric oxygen therapy as a treatment modality.
Bernbeck B; Christaras A; Krauth K; Lentrodt S; Strelow H; Schaper J; Janssen G; Mödder U; Göbel U
Klin Padiatr; 2004; 216(6):370-8. PubMed ID: 15565553
[TBL] [Abstract][Full Text] [Related]
39. The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia.
Badhiwala JH; Nayiager T; Athale UH
Pediatr Blood Cancer; 2015 Oct; 62(10):1851-4. PubMed ID: 25931304
[TBL] [Abstract][Full Text] [Related]
40. Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
Sawicka-Zukowska M; Kajdas L; Muszynska-Roslan K; Krawczuk-Rybak M; Sonta-Jakimczyk D; Szczepanski T
Pediatr Hematol Oncol; 2006 Dec; 23(8):625-9. PubMed ID: 17065138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
